Top 50 Pharma Tracker: eHCPs want the Novavax vaccine

04.10.2024 | Tracker

Top 50 Pharma Tracker: eHCPs want the Novavax vaccine

The Top 50 Pharmaceutical Companies mentioned by eHCPs on X

September
Rank
August
Rank
Company
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer2,3712057
22Moderna1,609509
39Novavax1,60417625
45Johnson & Johnson639751
54GSK53512316
67AstraZeneca47226010
711Novo Nordisk42321129
88Roche3281409
910Bayer308705
103Gilead Sciences241785
1113Merck & Co239747
1212Sanofi2218915
1314Abbott22020122
146Lilly155861
1519Boehringer Ingelheim1319920
1618AbbVie1218820
1717Novartis111660
1816Otsuka9870
1929BMS91406
2025Amgen89673
2115Fresenius86566
2227Regeneron62341
2326Chugai6022
2428Takeda60570
2539Astellas59330
2623Organon5070
2642Dr. Reddy's Labratories50270
2820Daiichi Sankyo47264
2837UCB47184
3022Biogen4190
3130STADA Arneimittel3740
3233Vertex28270
3321Teva24191
3324Eisai2460
3331Merck KGaA24207
3633Servier2270
3735Ipsen16102
3836Sun1210
3939CSL1070
4032Bausch841
4041Viatris800
4243Menarini711
4344Incyte650
4438Jazz Pharmaceuticals310
4544Grifols200
4650Jiangsu Hengrui100
5050Shanghai000
5050Sino000
5050Yunnan Baiyao Group000
5050Mitsubishi Chemical Group000

September’s insights from eHCPs mentioning the Top 50 Pharmaceutical Companies

The five most mentioned pharmaceutical companies by eHCPs on X in September 2024 were Pfizer, Moderna, Novavax, Johnson & Johnson and GSK.

5 most mentioned pharmaceutical companies by eHCPs on X in September 2024

CREATION.co identified 9,541 eHCP mentions of pharmaceutical companies in September 2024, an increase of 21.4% compared to the previous month.

September eHCP conversations about top 50 pharma on X.

On 04 September, eHCPs went on X to discuss the Novavax vaccine. The discussion came from a Novavax post – stating that their data indicated that the Novavax vaccine protects against the main circulating variants of the virus. One commenter described this update as “good news for Novavax fans”, which was shared by 2 eHCPs.

Shared by 2 eHCPs

On 23 September, the eHCP conversation around the Novavax vaccine picked up again. This time, eHCPs discussed the availability of the vaccine in Canada, where patients are struggling to get access to it. eHCPs shared an update that vaccine access is likely to be coming over the next month.

Shared by 98 eHCPs

The update for vaccine availability resonated strongly with eHCPs as 98 of them reshared this post. Public and eHCP calls for governing bodies to procure these vaccines was largely supported.

Nutritionist. 2 other eHCPs also shared a post with the same content.

On 26 September, eHCPs discussed the REGENCY trial by Roche, which evaluated obinutuzumab for the treatment of lupus nephritis. Nephrologist Juan Manuel Mejía shared the press release and applauded the results.

Shared by 5 eHCPs

The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:

  1. A Gilead press release for trial results for Lenacapavir for the prevention of HIV.
  2. An academic journal describing the association between SARS-CoV-2 viral load and COVID-19 vaccinations.
  3. A news report of Moderna’s mpox vaccine showing promising results.

——

Find out how the conversation is changing in other Top 50 Trackers and new analysis of the online HCP conversation in a variety of topics

 

You can also receive these updates and more straight to your inbox by signing up to CREATION.co’s monthly eJournal.

Methodology notes:

  • In September 2024, CREATION Pinpoint® identified 9,541 posts on X (Twitter) from 4,268 individual eHCPs mentioning a Top 50 Pharmaceutical company (based on revenue). 
  • Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 30 September 2024.
  • Unless otherwise specified, mentions of a company are not limited to its X account(s).
  • In some cases, a post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In September 2024, 68 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.

Share this article

Meet the Author

Aman Jandu

With a background working in IT systems administration, and leveraging a 1st Class degree in Digital Technologies, Aman uses his technical skills to apply a systematic approach to gather data and analyse insights.

Aman loves to Speedcube. While he can currently solve a Rubik’s Cube in around 20 seconds, he is learning how to complete it blindfolded.